WO2010123243A3 - 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물 - Google Patents

정소 추출물을 포함하는 질병 치료 또는 예방용 조성물 Download PDF

Info

Publication number
WO2010123243A3
WO2010123243A3 PCT/KR2010/002438 KR2010002438W WO2010123243A3 WO 2010123243 A3 WO2010123243 A3 WO 2010123243A3 KR 2010002438 W KR2010002438 W KR 2010002438W WO 2010123243 A3 WO2010123243 A3 WO 2010123243A3
Authority
WO
WIPO (PCT)
Prior art keywords
treating
diseases
composition containing
testis extract
therapeutic agent
Prior art date
Application number
PCT/KR2010/002438
Other languages
English (en)
French (fr)
Other versions
WO2010123243A2 (ko
Inventor
최인호
이동목
이은주
이기호
전용필
전태훈
Original Assignee
영남대학교 산학협력단
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020090035625A external-priority patent/KR101074377B1/ko
Priority claimed from KR1020090096976A external-priority patent/KR101227819B1/ko
Priority claimed from KR1020100028339A external-priority patent/KR20110108882A/ko
Application filed by 영남대학교 산학협력단 filed Critical 영남대학교 산학협력단
Publication of WO2010123243A2 publication Critical patent/WO2010123243A2/ko
Publication of WO2010123243A3 publication Critical patent/WO2010123243A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Immunology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물에 관한 것으로, 보다 상세하게는 가축류의 정소에서 아나볼릭스테로이드를 포함하는 성호르몬을 분리한 천연물인 정소 추출물을 피임약, 골다공증치료제, 빈혈치료제, 소모성 근육퇴화 질환 치료제, 성기능장애 치료제, 면역질환 치료제, 창상 치료제 등으로 사용함으로써 종래 사용해 온 스테로이드제를 대체할 수 있어 스테로이드제의 부작용을 줄이면서 광범위한 인체 질병을 치료할 수 있다.
PCT/KR2010/002438 2009-04-23 2010-04-20 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물 WO2010123243A2 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
KR1020090035625A KR101074377B1 (ko) 2009-04-23 2009-04-23 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물
KR10-2009-0035625 2009-04-23
KR1020090096976A KR101227819B1 (ko) 2009-10-12 2009-10-12 정소 추출물을 함유하는 면역세포 증식 억제제
KR10-2009-0096976 2009-10-12
KR10-2010-0028339 2010-03-30
KR1020100028339A KR20110108882A (ko) 2010-03-30 2010-03-30 정소 추출물을 유효성분으로 함유하는 창상 치료용 약학조성물

Publications (2)

Publication Number Publication Date
WO2010123243A2 WO2010123243A2 (ko) 2010-10-28
WO2010123243A3 true WO2010123243A3 (ko) 2011-04-14

Family

ID=43011585

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2010/002438 WO2010123243A2 (ko) 2009-04-23 2010-04-20 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물

Country Status (1)

Country Link
WO (1) WO2010123243A2 (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103018389B (zh) * 2011-09-23 2015-01-07 北大方正集团有限公司 高效液相色谱分析方法及其应用

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
"RECENT PROGRESS IN HORMONE RESEARCH", ENDOCRINE SOCIETY, 2002 *
JULES FREUND, GEORGE E. THOMPSON, AND MURRAY M. LIPTON: "ASPERMATOGENESIS, ANAPHYLAXIS, AND CUTANEOUS SENSITIZATION INDUCED IN THE GUINEA PIG BY HOMOLOGOUS TESTICULAR EXTRACT", J EXP MED., vol. 101, no. 6, 1 June 1955 (1955-06-01), pages 591 - 604 *
MJA, vol. 177, 2002, pages 678 - 679 *
SHEHZAD BASARIA, JUSTIN T. WAHLSTROM, AND ADRIAN S. DOBS: "CLINICAL REVIEW 138: Anabolic-Androgenic Steroid Therapy in the Treatment of Chronic Diseases", THE JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, vol. 86, no. 11, 2001, pages 5108 - 5117 *

Also Published As

Publication number Publication date
WO2010123243A2 (ko) 2010-10-28

Similar Documents

Publication Publication Date Title
WO2011102684A3 (ko) 태반 추출물을 포함하는 조성물
UA106634C2 (uk) Тверда фармацевтична дозована форма
PH12015502691A1 (en) Use of high dose pridopidine for treating huntington's disease
MY155649A (en) Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
GB2491327A (en) Delayed prolonged drug delivery
EA201201403A1 (ru) Очень низкодозированные твердые пероральные лекарственные формы для гзт
CU20120175A7 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
WO2008116890A3 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
MY151048A (en) Use of flibanserin for the treatment of post-menopausal sexual desire disorders
WO2012075081A3 (en) High-strength testosterone undecanoate compositions
EA201400202A1 (ru) Применение эстетрола в качестве экстренного контрацептива
MX2018007844A (es) Derivado de benzopiperidina, metodo de preparacion del mismo y su uso medico del mismo.
UA109414C2 (uk) Арильовані камфени та фармацевтична композиція на їх основі
CR20200291A (es) Composiciones y métodos para el tratamiento de enfermedades metabólicas
WO2011127048A3 (en) NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
WO2010147440A3 (ko) 밤껍질 추출물을 포함하는 건강 식품 또는 약학 조성물
MX2016009217A (es) Inmunoterapia basada en liposomas.
EP3643302C0 (en) COMPOSITION WITH SESQUITERPENDERIVATE AS AN ACTIVE INGREDIENT FOR THE PREVENTION OR TREATMENT OF MUSCLE DISEASES
WO2010123243A3 (ko) 정소 추출물을 포함하는 질병 치료 또는 예방용 조성물
WO2014193269A3 (ru) Лекарственное средство на основе дииндолилметана и его применение для лечения гриппа и респираторных вирусных инфекций
ZA201908404B (en) 15.beta.-[3-propanamido]-substituted estra-1,3,5(10)-trien-17-one compounds and their 17-oximes for use in inhibition of 17.beta.-hydroxysteroid dehydrogenases
NZ735025A (en) Use of fenugreek extract to enhance psychological, somatic, and sexual conditions in aging males
NZ598856A (en) Preventative agent and/or therapeutic agent and/or exacerbation-suppressing agent for human knee osteoarthritis
BR112013000296A2 (pt) agentes terapêuticos 976
MX2018006882A (es) Composiciones farmacéuticas de estradiol insertadas por vía vaginal y métodos.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10767257

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10767257

Country of ref document: EP

Kind code of ref document: A2